NCT06539598

Brief Summary

This is a prospective interventional study of patients with Friedreich's Ataxia that receive respiratory strength training for a period of 12 weeks with two research visits at the beginning and at the end of the study period. Visits include swallowing evaluation with fiberoptic endoscopic evaluation of swallowing, pulmonary function testing, surface electromyography and patient surveys.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
23 days until next milestone

Study Start

First participant enrolled

August 29, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2025

Completed
Last Updated

November 3, 2025

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

July 30, 2024

Last Update Submit

October 30, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Force Vital Capacity

    Forced Vital Capicity will be measured before and after the 12 week intervention

    Through study completion (4 months)

  • Maximal Inspiratory Pressure (MIP)

    Maximal Inspiratory Pressure (MIP) will be measured before and after the 12 week intervention

    Through study completion (4 months)

  • Maximal Expiratory Pressure (MEP)

    Maximal Expiratory Pressure (MEP) will be measured before and after the 12 week intervention

    Through study completion (4 months)

  • Sniff Nasal Inspiratory Pressure (SNIP)

    Sniff Nasal Inspiratory Pressure (SNIP) will be measured before and after the 12 week intervention

    Through study completion (4 months)

  • Swallowing

    Fiberoptic Endoscopic Evaluation of Swallowing (FEES) will be measured before and after the 12 week intervention.

    Through study completion (4 months)

  • Surface Electromyography (sEMG)

    sEMG will be placed on the skin to measure muscle activity involved in breathing and swallowing

    Through study completion (4 months)

  • Diaphragm Ultrasound

    Diaphragm movement will be measured through an ultrasound probe positioned on the skin before and after the 12 week intervention.

    Through study completion (4 months)

Study Arms (1)

Respiratory Strength Training (RST)

EXPERIMENTAL

Participants will receive a respiratory strength training device to take home and use up to 5 times a week for 12 weeks.

Other: Respiratory Strength Training (RST)

Interventions

Respiratory Strength training involves inhaling/exhaling against a fix resistant to potentially increase respiratory strength

Respiratory Strength Training (RST)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • confirmed genetic testing of Friedreich's Ataxia
  • have an overall DIGEST score of 1 or higher based on FEES screening
  • are able to perform pulmonary function testing

You may not qualify if:

  • have been on antibiotics within 15 days prior to baseline screening.
  • have been prescribed systemic corticosteroids or neuromuscular blocking agents within 15 days of the baseline screening
  • have an allergy or contraindication to topical lidocaine or oxymetazoline
  • have any other concurrent medical condition which, in the opinion of the investigators, would make the subject inappropriate to participate in testing or respiratory exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Research Center

Gainesville, Florida, 32610, United States

Location

MeSH Terms

Conditions

Friedreich Ataxia

Condition Hierarchy (Ancestors)

Spinocerebellar DegenerationsCerebellar DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSpinal Cord DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMitochondrial DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Carmen Leon Astudillo, MD

    University of Florida

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 6, 2024

Study Start

August 29, 2024

Primary Completion

August 7, 2025

Study Completion

August 7, 2025

Last Updated

November 3, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations